Facultad de Farmacia Contacto
I+DNanomed
Investigación y Desarrollo Tecnológico en Nanomedicina
Inicio
Publicaciones
Publicaciones 2016-2020
Actualizado el 20/02/2023
2020
Gender differences in aortic valve replacement: Is surgical aortic valve replacement riskier and transcatheter aortic valve replacement safer in women than in men?.
Caponcello, M.G.; Martín Banderas, L.; Ferrero, C.; Bramlage, C.; Thoenes, M.; Bramlage, P. Journal of Thoracic Disease, 12 (7), 3737 – 3746 (2020)
Improved antileishmanial activity and cytotoxicity of a novel nanotherapy for N-iodomethyl-N,N-dimethyl-N-(6,6-diphenylhex-5-en-1-yl)ammonium iodide.
Fernández, Maritza; Holgado, M.Á.; Cayero-Otero, M.D; Pineda, T.; Yepes, L.M.; Gaspar, D.P.; Almeida, A.J.; Robledo, S.M.; Martín-Banderas, L. Journal of Drug Delivery Science and Technology, art. nº 101988, (2020)
Oral Delivery of Biologics for Precision Medicine.
Durán-Lobato, M.; Niu, Z.; Alonso, M.J. Advanced Materials, 32 (13), art. nº 1901935 (2020)
2019
An update on liposomes in drug delivery: a patent review (2014-2018).
M.M. El-Hammadi, J.L. Arias. Expert Opinion on Therapeutic Patents, 29 (11), 891 – 9072 (2019)
A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.
Jiménez-López, J., El-Hammadi, M.M., Ortiza, R., Cayero-Otero, M.D., Cabeza, L., Perazzolia, G., Martin-Bandera, L., Baeyense, J.M., Prados, J., Melguizo, C. Pharmacological Research, 141, 451-465 (2019)
Contact lenses as drug-delivery systems: a promising therapeutic tool.
Holgado, M. A.; Anguiano-Domínguez, A.; Martín-Banderas, L. Archivos de la Sociedad Española de Oftalmología, 95 (1), 24-33 (2019)
Dexketoprofen trometamol-loaded poly-lactic-co-glycolic acid (PLGA) nanoparticles: Preparation, in vitro characterization and cyctotoxity.
Öztürk, A. A.; Martín-Banderas, L.; Cayero-Otero, M.D.; Yenilmez, E.; Şenel, B.; Yazan, Y. Tropical Journal of Pharmaceutical Research , 18 (1), 1-11 (2019)
In vivo biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles.
Cayero-Otero, M. D.; Gomes, Maria João; Martins, Cláudia; Álvarez-Fuentes, J.; Fernández-Arévalo, M.; Sarmento, B.; Martín-Banderas, L.  Expert Opinion on Drug Delivery, 16 (12), 1413-1427 (2019)
2018
New Approach to Hypertension Treatment: Carvediol-Loaded PLGA Nanoparticles, Preparation, In Vitro Characterization and Gastrointestinal Stability.
Ozturk, A.A., Martin Banderas, L., Cayero-Otero, M.D., Yenilmez, E., Yazan, Y. Latin American Journal of Pharmacy, 37(9), 1730-1741 (2018)
PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy.
Niu, ZG; Samaridou, E; Jaumain, E; Coene, J; Ullio, G; Shrestha, N; Garcia, J; Duran-Lobato, M; Tovar, S; Santander-Orteg, MJ; Lozano, MV; Arroyo-Jimenez, MM; Ramos-Membrive, R; Penuelas, I; Mabondzo, A; Preat, V; Teixido, M; Giralt, E; Alonso, MJ. Journal of Controlled Release, 276, 125-139 (2018)
Potential Use of Nanomedicine for the Anti-inflammatory Treatment of Neurodegenerative Diseases.
Cayero-Otero, M.D., Espinosa-Oliva, A.M., Herrera, A.J., Garcia-Dominguez, I., Fernandez-Arevalo, M., Martin-Banderas, L., de Pablos, R.M. Current Pharmaceutical Design, 24(14), 1589-1616 (2018)
2017
Neuroprotective effect of cannabinoids nanoplatforms in neurodegenerative diseases. Journal of Drug Delivery Science and Technology, 42, 84-93 (2017)
M.A. Holgado, L. Martin-Banderas, J. Álvarez-Fuentes, M. Fernández-Arévalo.
Single oral dose of cannabinoid derivate loaded PLGA nanocarriers relieves neuropathic pain for eleven days. Nanomedicine-Nanotechnology Biology and Medicine, 13, 8, 2623-2632 (2017)
E. Berrocoso, R. Rey-Brea, M. Fernández-Arévalo, J.A. Micó, L. Martín-Banderas.
2016
Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility
Duran-Lobato, M.; Martin-Banderas, L.; Lopes, R.; Goncalves, L.M.D.; Fernandez-Arevalo, M.; Almeida, A.J. Drug Development and Industrial Pharmacy, 42, (2), 190-198 (2016)
Role of Nanotechnology for Enzyme Replacement Therapy in Lysosomal Diseases. A Focus on Gaucher's Disease
Martin-Banderas, L.; Holgado, M.A.; Duran-Lobato, M.; Infante, J.J.; Alvarez-Fuentes, J.; Fernandez-Arevalo, M. Current Medicinal Chemistry, 23, (9), 929-952 (2016)
Actualizado el 20/02/2023

Usamos Cookies para obtener estadísticas anónimas de uso de la Web. Si sigues navegando, aceptas su uso. Más información.

Grupo de Investigación I+DNanomed (CTS480)
Facultad de Farmacia. Universidad de Sevilla
Desarrolla: Equipo Web